
Sotera Health (SHC) Stock Forecast & Price Target
Sotera Health (SHC) Analyst Ratings
Bulls say
Sotera Health is a promising investment opportunity as the company has shown consistent growth in revenue, beating expectations in all three segments. The recent legal settlements and their balanced legal strategy show a promising outlook for continued de-risking and potential increase in valuation for the stock. With a new CEO in place and a strategic planning process underway, growth acceleration is expected both organically and inorganically.
Bears say
Sotera Health is facing a new CEO transition, with Alton Shader taking over from outgoing CEO Michael Petras. The company delivered strong growth in its Sterigenics segment, driven by pricing and despite weather-related headwinds. Additionally, the company has seen positive outcomes in ongoing litigation cases, which should help to further mitigate risks. However, looming questions regarding commercial execution and litigation processes may continue to weigh on investors' minds.
This aggregate rating is based on analysts' research of Sotera Health and is not a guaranteed prediction by Public.com or investment advice.
Sotera Health (SHC) Analyst Forecast & Price Prediction
Start investing in Sotera Health (SHC)
Order type
Buy in
Order amount
Est. shares
0 shares